Yoshiteru Takekita
Yoshiteru Takekita
Kansai Medical University
Verified email at takii.kmu.ac.jp
TitleCited byYear
ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder
M Kato, T Fukuda, A Serretti, M Wakeno, G Okugawa, Y Ikenaga, Y Hosoi, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (2), 398-404, 2008
1582008
ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder
M Kato, T Fukuda, A Serretti, M Wakeno, G Okugawa, Y Ikenaga, Y Hosoi, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (2), 398-404, 2008
1582008
Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese …
M Kato, T Fukuda, M Wakeno, K Fukuda, G Okugawa, Y Ikenaga, ...
Neuropsychobiology 53 (4), 186-195, 2006
1372006
Effect of 5‐HT1A gene polymorphisms on antidepressant response in major depressive disorder
M Kato, T Fukuda, M Wakeno, G Okugawa, Y Takekita, S Watanabe, ...
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 150 …, 2009
942009
Differences in quantitative EEG between frontotemporal dementia and Alzheimer’s disease as revealed by LORETA
K Nishida, M Yoshimura, T Isotani, T Yoshida, Y Kitaura, A Saito, H Mii, ...
Clinical Neurophysiology 122 (9), 1718-1725, 2011
372011
The alpha 2A-adrenergic receptor gene polymorphism modifies antidepressant responses to milnacipran
M Wakeno, M Kato, G Okugawa, T Fukuda, Y Hosoi, Y Takekita, ...
Journal of clinical psychopharmacology 28 (5), 518-524, 2008
352008
Antidepressant response and intolerance to SSRI is not influenced by G-protein β3 subunit gene C825T polymorphism in Japanese major depressive patients
M Kato, M Wakeno, G Okugawa, T Fukuda, Y Takekita, Y Hosoi, J Azuma, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (4), 1041-1044, 2008
332008
Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects
M Kato, G Okugawa, M Wakeno, Y Takekita, S Nonen, S Tetsuo, ...
European neuropsychopharmacology 19 (10), 718-725, 2009
272009
HTR1A gene polymorphisms and 5-HT1A receptor partial agonist antipsychotics efficacy in schizophrenia
Y Takekita, C Fabbri, M Kato, S Nonen, S Sakai, N Sunada, Y Koshikawa, ...
Journal of clinical psychopharmacology 35 (3), 220-227, 2015
152015
Remifentanil in electroconvulsive therapy: a systematic review and meta-analysis of randomized controlled trials
Y Takekita, T Suwa, N Sunada, H Kawashima, C Fabbri, M Kato, A Tajika, ...
European archives of psychiatry and clinical neuroscience 266 (8), 703-717, 2016
142016
The comparative effects of risperidone long-acting injection and paliperidone palmitate on social functioning in schizophrenia: a 6-month, open-label, randomized controlled …
Y Koshikawa, Y Takekita, M Kato, S Sakai, A Onohara, N Sunada, ...
Neuropsychobiology 73 (1), 35-42, 2016
132016
5-HTTLPR rs25531A> G differentially influence paroxetine and fluvoxamine antidepressant efficacy: a randomized, controlled trial
M Kato, S Nonen, J Azuma, A Serretti, S Tetsuo, Y Takekita, T Kinoshita
Journal of clinical psychopharmacology 33 (1), 131-132, 2013
132013
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
Y Takekita, Y Koshikawa, C Fabbri, S Sakai, N Sunada, A Onohara, ...
BMC psychiatry 16 (1), 172, 2016
122016
Genetic variants in combination with early partial improvement as a clinical utility predictor of treatment outcome in major depressive disorder: the result of two pooled RCTs
M Kato, A Serretti, S Nonen, Y Takekita, M Wakeno, J Azuma, T Kinoshita
Translational psychiatry 5 (2), e513, 2015
112015
HTR1A polymorphisms and clinical efficacy of antipsychotic drug treatment in schizophrenia: a meta-analysis
Y Takekita, C Fabbri, M Kato, Y Koshikawa, A Tajika, T Kinoshita, ...
International Journal of Neuropsychopharmacology 19 (5), pyv125, 2015
102015
A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients
Y Takekita, M Kato, M Wakeno, S Sakai, A Suwa, K Nishida, G Okugawa, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 40, 110-114, 2013
102013
Syndrome of inappropriate secretion of anti‐diuretic hormone in an elderly depressive patient receiving paroxetine: a case report
A Suwa, M Wakeno, A Tajika, M Kato, T Sugimoto, K Nishida, S Sakai, ...
International Journal of Geriatric Psychiatry: A journal of the psychiatry …, 2010
102010
Polymorphism of rs3813034 in serotonin transporter gene SLC6A4 is associated with the selective serotonin and serotonin-norepinephrine reuptake inhibitor response in depressive …
S Nonen, M Kato, Y Takekita, M Wakeno, S Sakai, A Serretti, T Kinoshita
Journal of clinical psychopharmacology 36 (1), 27-31, 2016
72016
Case of adult‐onset type II citrullinemia treated as schizophrenia for a long time
M Kyo, H Mii, Y Takekita, D Tokuhara, M Yazaki, Y Nakamori, S Kono, ...
Psychiatry and clinical neurosciences 69 (5), 306-307, 2015
72015
Neuropsychological Evaluation and Cerebral Blood Flow Effects of Apolipoprotein E4 in Alzheimer's Disease Patients after One Year of Treatment: An Exploratory Study
A Suwa, K Nishida, K Utsunomiya, S Nonen, M Yoshimura, Y Takekita, ...
Dementia and geriatric cognitive disorders extra 5 (3), 414-423, 2015
72015
The system can't perform the operation now. Try again later.
Articles 1–20